Qiong Du Selected Research

Qiong Du Research Topics

Disease

16	Neoplasms (Cancer) 12/2024 - 12/2013
4	Breast Neoplasms (Breast Cancer) 01/2023 - 03/2020
3	Adenocarcinoma 12/2024 - 01/2020
3	Neoplasm Metastasis (Metastasis) 04/2024 - 03/2020
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2020
3	Hypertension (High Blood Pressure) 01/2020 - 01/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2024 - 10/2023
2	Cancer Pain 09/2022 - 03/2022
2	Vascular Calcification 12/2019 - 06/2019
2	Hemorrhage 06/2019 - 01/2013
2	Colorectal Neoplasms (Colorectal Cancer) 10/2017 - 01/2017
2	Gingivitis 08/2015 - 01/2013
1	Chemical and Drug Induced Liver Injury 01/2024
1	Ascites 01/2024
1	Colitis 01/2023
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Alopecia (Baldness) 01/2023
1	Anemia 01/2023
1	Asthenia 01/2023
1	Cholestasis 01/2023
1	Diarrhea 01/2023
1	Hyperalgesia 01/2023
1	Sepsis (Septicemia) 01/2023
1	Leukopenia 01/2023
1	Meningitis 01/2023
1	Neuralgia (Stump Neuralgia) 01/2023
1	Neutropenia 01/2023
1	Pain (Aches) 09/2022
1	Hypersensitivity (Allergy) 12/2021
1	COVID-19 10/2021
1	Febrile Neutropenia 05/2021
1	Colonic Neoplasms (Colon Cancer) 02/2021
1	Hypoxia (Hypoxemia) 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

3	MicroRNAs (MicroRNA)IBA 12/2024 - 01/2017
3	Long Noncoding RNAIBA 01/2020 - 01/2017
2	LigandsIBA 12/2024 - 04/2021
2	Biomarkers (Surrogate Marker)IBA 12/2024 - 01/2020
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2023 - 01/2020
2	Surface Antigens (Surface Antigen)IBA 01/2023 - 02/2021
2	Opioid Analgesics (Opioids)IBA 09/2022 - 03/2022
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2021 - 09/2017
2	Transcription Factors (Transcription Factor)IBA 04/2021 - 01/2017
2	AnthracyclinesIBA 03/2020 - 01/2017
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2019 - 01/2017
2	Volatile Oils (Essential Oils)IBA 08/2015 - 01/2013
1	Exosome Multienzyme Ribonuclease ComplexIBA 12/2024
1	SuspensionsIBA 12/2024
1	human MIRN1293 microRNAIBA 12/2024
1	Everolimus FDA Link 04/2024
1	surufatinibIBA 04/2024
1	Sunitinib (Sutent)FDA Link 04/2024
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 04/2024
1	abemaciclibIBA 01/2024
1	palbociclibIBA 01/2024
1	ribociclibIBA 01/2024
1	Albumin-Bound Paclitaxel FDA Link 10/2023
1	Gemcitabine FDA Link 10/2023
1	ProteomeIBA 10/2023
1	1- (2- (3- (4- methoxyphenyl)propoxy)- 4- methoxyphenylethyl)- 1H- imidazoleIBA 01/2023
1	BilirubinIBA 01/2023
1	CalciumIBA 01/2023
1	ElectrolytesIBA 01/2023
1	Immunoconjugates (Immunoconjugate)IBA 01/2023
1	sacituzumab govitecanIBA 01/2023
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2022
1	Hormones (Hormone)IBA 02/2022
1	Epidermal Growth Factor (EGF)IBA 02/2022
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021
1	PlatinumIBA 12/2021
1	Bevacizumab (Avastin)FDA Link 12/2021
1	XELOXIBA 12/2021
1	VaccinesIBA 10/2021
1	COVID-19 VaccinesIBA 10/2021
1	pegfilgrastim (Neulasta)FDA Link 05/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 05/2021
1	Docetaxel (Taxotere)FDA Link 05/2021
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 04/2021
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 04/2021
1	Environmental Pollutants (Pollutants, Environmental)IBA 04/2021
1	Gefitinib (Iressa)FDA Link 01/2021
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	PPAR gammaIBA 01/2021
1	Sirtuin 1IBA 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Lapatinib (GW572016)FDA Link 03/2020
1	Capecitabine (Xeloda)FDA Link 03/2020
1	Trastuzumab (Herceptin)FDA Link 03/2020
1	taxaneIBA 03/2020
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020

Therapy/Procedure

5	Therapeutics 04/2024 - 03/2020
5	Drug Therapy (Chemotherapy) 10/2023 - 01/2017
1	Neoadjuvant Therapy 10/2023
1	Pain Management 01/2023
1	Spinal Injections 01/2023
1	Analgesia 09/2022
1	Premedication 12/2021
1	Immunotherapy 01/2021